Oon , Chern Ein (2016) Fundamental studies on the mechanism of action of a novel sirtuin inhibitor (BZD9L 1) in colorectal cancer cells- towards the elucidation of a novel cancer therapeutic agent. Technical Report. Universiti Sains Malaysia.
Full text not available from this repository.Abstract
Gemcitabine remains the standard treatment for pancreatic cancer. although most patients acquire resistance to the therapy. Up-regulated in pancreatic cancer. SIRTI is involved in tumorigenesis and drug resistance, However the mechanism through which SIRTl regulates drug sensitivity in cancer cells is mainly unknown.
| Item Type: | Monograph (Technical Report) |
|---|---|
| Subjects: | R Medicine > R Medicine (General) > R735-854 Medical education. Medical schools. Research |
| Divisions: | Institut Penyelidikan Perubatan Molekul (Institute for Research in Molecular Medicine INFORMM) > Monograph |
| Depositing User: | Mr Erwan Roslan |
| Date Deposited: | 03 Oct 2017 08:13 |
| Last Modified: | 03 Oct 2017 08:13 |
| URI: | http://eprints.usm.my/id/eprint/36903 |
Actions (login required)
 |
View Item |
